Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;1207 Suppl 1(Suppl 1):E94-102.
doi: 10.1111/j.1749-6632.2010.05752.x.

Lymphatic system: a vital link between metabolic syndrome and inflammation

Affiliations
Review

Lymphatic system: a vital link between metabolic syndrome and inflammation

Sanjukta Chakraborty et al. Ann N Y Acad Sci. 2010 Oct.

Abstract

Metabolic syndrome is defined by a cluster of different metabolic risk factors that include overall and central obesity, elevated fasting glucose levels, dyslipidemia, hypertension, and intimal atherogenesis. Metabolic syndrome leads to increased risk for the development of type 2 diabetes and cardiovascular disease (e.g., heart disease and stroke). The exacerbated progression of metabolic syndrome to cardiovascular disease has lead to intense study of the physiological ramifications of metabolic syndrome on the blood vasculature. These studies have particularly focused on the signaling and architectural alterations that manifest in hypertension and atherosclerosis. However, despite the overlap of metabolic syndrome pathology with lymphatic function, tangent effects on the lymphatic system have not been extensively documented. In this review, we discuss the current status of metabolic syndrome and provide evidence for, and the remaining challenges in studying, the connections among the lymphatic system, lipid transport, obesity, insulin resistance, and general inflammation.

Keywords: inflammation; lymphatic pump; lymphatics and lipid transport; metabolic syndrome.

PubMed Disclaimer

References

    1. GRUNDY SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol & Metab. 2004;89:2595–2600. - PubMed
    1. GRUNDY SM, CLEEMAN JL, DANIELS SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. American Heart Association; National Heart, Lung, and Blood Institute. Circulation. 2005;112:2735–52. - PubMed
    1. BASCIANO H, FEDERICO L, ADELI K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005;2:5. - PMC - PubMed
    1. FESKENS EJ, VIRTANEN SM, RÄSÄNEN L, et al. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care. 1995;18(8):1104–12. - PubMed
    1. HILL JO, LIN D, YAKUBU F, et al. Development of dietary obesity in rats: influence of amount and composition of dietary fat. Int J Obes Relat Metab Disord. 1992;16:321–33. - PubMed

Publication types